Chunyan Gu, PhD


Research Assistant


chunyan-gu@uiowa.edu

1132 Medical Laboratories
500 Newton Road
University of Iowa
Iowa City, IA 52242-1109

Lab: 319-335-9986

Training

Postdoctoral Fellow, Nephrology, University of Utah School of Medicine
PhD, Pathology, Nanjing Medical University, China
MS, Pathology and Pathophysiology, Nanjing Medical University, China
BS, Pathology, Nanjing Medical University, China

Research

Role of the transcription factor FOXM1 in multiple myeloma.

Publications

  1. Yang Y, Gu C, Luo C, Li F, Wang M. BUB1B promotes multiple myeloma cell proliferation through CDC20/CCNB axis. Med Oncol. 2015, 32(3):81.
  2. Han SS, Tompkins VS, Son DJ, Han S, Yun H, Kamberos NL1, Dehoedt CL, Gu C, Holman C, Tricot G, Zhan F, Janz S. CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma. Exp Hematol Oncol. 2015, 4:9.
  3. Gu C, Zhou G, Noble NA, Border WA, Cheung AK, Huang Y. Targeting reduction of proteinuria in glomerulonephritis: Maximizing the antifibrotic effect of valsartan by protecting podocytes. J Renin Angiotensin Aldosterone Syst. 2014, 15(2):177-89.
  4. Zhang J*, Gu C*, Lawrence DA, Noble NA, Cheung AK, and Huang Y. PAI-1 mutant retards diabetic nephropathy in db/db mice through protecting podocytes. Exp Physiol. 2014, 99(5):802-15.
  5. Zhang J, Gu C, Noble NA, Border WA, Huang Y. Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis. Am J Physiol Renal Physiol. 2011, 301(4):F723-32.
  6. Zhang J, Wu J, Gu C, Noble NA, Border WA, Huang Y. Receptor-mediated nonproteolytic activation of prorenin and induction of TGF-β1 and PAI-1 expression in renal mesangial cells. Am J Physiol Renal Physiol. 2012, 303(1):F11-20.
  7. Hong Li, Gu C, Yongya Ren, et al. The efficacy of NP11-4-derived immunotoxin scFv-artesunate in reducing hepatic fibrosis induced by Schistosoma japonicum in mice. J Biomed Res, 2011, 25(2): 148-154.